These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23496844)

  • 1. Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy.
    Grah JJ; Katalinic D; Stern-Padovan R; Paladino J; Santek F; Juretic A; Zarkovic K; Plestina S; Supe M
    World J Surg Oncol; 2013 Mar; 11():55. PubMed ID: 23496844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Stem and Entire Spinal Leptomeningeal Dissemination of Supratentorial Glioblastoma Multiforme in a Patient during Postoperative Radiochemotherapy: Case Report and Review of the Literatures.
    Kong X; Wang Y; Liu S; Chen K; Zhou Q; Yan C; He H; Gao J; Guan J; Yang Y; Li Y; Xing B; Wang R; Ma W
    Medicine (Baltimore); 2015 Jun; 94(24):e962. PubMed ID: 26091464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide.
    Kuo LT; Tsai SY; Yang CY; Lin LW
    Asian J Surg; 2017 Jan; 40(1):61-65. PubMed ID: 23978432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature.
    Fiorentino A; Caivano R; Chiumento C; Cozzolino M; Fusco V
    Int J Neurosci; 2012 Nov; 122(11):691-4. PubMed ID: 22720749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic leptomeningeal and intramedullary metastases from intracranial glioblastoma multiforme: a case report.
    Scoccianti S; Detti B; Meattini I; Iannalfi A; Sardaro A; Leonulli BG; Martinelli F; Bordi L; Pellicanò G; Biti G
    Tumori; 2008; 94(6):877-81. PubMed ID: 19267111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
    Schwartz C; Romagna A; Machegger L; Weiss L; Huemer F; Fastner G; Kleindienst W; Weis S; Greil R; Winkler PA
    World Neurosurg; 2018 Dec; 120():442-447. PubMed ID: 30253992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
    Abrey LE
    Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881
    [No Abstract]   [Full Text] [Related]  

  • 9. Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease.
    Lawton CD; Nagasawa DT; Yang I; Fessler RG; Smith ZA
    J Neurosurg Spine; 2012 Nov; 17(5):438-48. PubMed ID: 22958073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib.
    Seiz M; Nölte I; Pechlivanis I; Freyschlag CF; Schmieder K; Vajkoczy P; Tuettenberg J
    Neurosurg Rev; 2010 Jul; 33(3):375-81; discussion 381. PubMed ID: 20306105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide.
    Tseng HM; Kuo LT; Lien HC; Liu KL; Liu MT; Huang CY
    Anticancer Drugs; 2010 Nov; 21(10):963-7. PubMed ID: 20838208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
    Malik D
    Clin Nucl Med; 2021 Feb; 46(2):138-139. PubMed ID: 33234937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
    Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drop metastases to the spinal cord from infratentorial glioblastoma multiforme in post-temozolomide era.
    Pande SB; Pavithran K
    J Cancer Res Ther; 2015; 11(4):1039. PubMed ID: 26881656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in glioblastoma multiforme survival: the role of temozolomide.
    Dubrow R; Darefsky AS; Jacobs DI; Park LS; Rose MG; Laurans MS; King JT
    Neuro Oncol; 2013 Dec; 15(12):1750-61. PubMed ID: 24046259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Outcomes of Primary Spinal Cord Glioblastoma: A Single-Center Experience and Literature Review.
    Yang K; Man W; Jing L; Sun Z; Liang P; Wang J; Wang G
    World Neurosurg; 2020 Nov; 143():e157-e165. PubMed ID: 32688042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.
    Michaelsen SR; Christensen IJ; Grunnet K; Stockhausen MT; Broholm H; Kosteljanetz M; Poulsen HS
    BMC Cancer; 2013 Sep; 13():402. PubMed ID: 24004722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
    Rock K; McArdle O; Forde P; Dunne M; Fitzpatrick D; O'Neill B; Faul C
    Br J Radiol; 2012 Sep; 85(1017):e729-33. PubMed ID: 22215883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.